Genus plc (GNS), the global animal genetics company, has disclosed that it purchased a total of 155,695 of its own ordinary shares during the five-day period from 2 November 2026 to 6 November 2026, acting through J.P. Morgan Securities plc. The announcement, made in accordance with UKLR 9.6.6R, confirms that all purchased shares will be cancelled rather than held in treasury. The buyback reduces the total number of ordinary shares in circulation, a development that investors in the FTSE-listed livestock genetics business may note as part of ongoing capital management activity.

Key Points

  • Genus plc (GNS) — global animal genetics company listed on the London Stock Exchange
  • Genus purchased 155,695 ordinary shares of 10 pence each between 2 and 6 November 2026 via J.P. Morgan Securities plc
  • Volume weighted average prices ranged from approximately 2,367.67 pence to 2,419.32 pence across the five trading days
  • Investors should watch for further buyback tranches and any update on the total programme size or remaining authority

Genus Purchases 155,695 Shares Across Five Trading Days via J.P. Morgan

The company announced purchases on each trading day during the period, with daily volumes ranging from 29,825 shares on 6 November 2026 to 32,029 shares on 4 November 2026. J.P. Morgan Securities plc executed all transactions on behalf of Genus. The lowest price paid across the entire period was 2,292.00 pence per share, recorded on 2 November 2026, while the highest single price paid was 2,448.00 pence per share, recorded on 5 November 2026. The disclosure was made under UKLR 9.6.6R and Article 5(1)(b) of Regulation (EU) No 596/2014 as retained in UK domestic law.

Daily Volume Weighted Average Prices Range From 2,367.67p to 2,419.32p

Aggregated data published in the announcement shows the volume weighted average price (VWAP) paid per ordinary share moved within a relatively contained band during the week. The highest VWAP of 2,419.3166 pence was recorded on 5 November 2026, while the lowest VWAP of 2,367.6707 pence occurred on 6 November 2026. The VWAP on the opening day of the period, 2 November 2026, stood at 2,370.1691 pence. Full disaggregated data covering individual transactions within each day has been published separately via the London Stock Exchange's RNS-PDF service, as required under applicable UK market regulations.

All Purchased Shares to Be Cancelled, Reducing Genus's Ordinary Share Capital

Genus has confirmed that the 155,695 ordinary shares of 10 pence each acquired during the period will be cancelled. Cancellation, rather than holding shares in treasury, directly reduces the company's issued share capital, which can influence earnings per share calculations and return metrics over time. Genus operates across global livestock genetics markets, supplying pig and bovine genetics under its PIC and ABS brands respectively. The company did not disclose the total buyback programme size, the remaining authority, or the total capital deployed in this tranche within this announcement.